Last Posted: Feb 14, 2020
- An Emerging Paradigm for Germline Testing in Pancreatic Ductal Adenocarcinoma and Immediate Implications for Clinical Practice-A Review
M Rainone et al, JAMA Oncology, February 13, 2020 - Family history of pancreatic cancer in BRCA1/2 testing criteria.
Toss A et al. Annals of oncology : official journal of the European Society for Medical Oncology 2017 Oct 28 Suppl 6vi46 - Promoter methylation of ADAMTS1 and BNC1 as potential biomarkers for early detection of pancreatic cancer in blood.
Eissa Maryam A L et al. Clinical epigenetics 2019 11(1) 59 - Impact of hereditary pancreatitis on patients and their families.
Shelton Celeste A et al. Journal of genetic counseling 2020 Feb - Machine Learning and Network Analyses Reveal Disease Subtypes of Pancreatic Cancer and their Molecular Characteristics
M Sinkala et al, Scientific Reports, January 27, 2020 - COL6A1 promotes metastasis and predicts poor prognosis in patients with pancreatic cancer.
Owusu-Ansah Kwabena Gyabaah et al. International journal of oncology 2019 Aug 55(2) 391-404 - Genetic landscape of prognostic value in pancreatic ductal adenocarcinoma microenvironment.
Pu Ning et al. Annals of translational medicine 2019 Nov 7(22) 645 - Identification of potential biomarkers for diagnosis of pancreatic and biliary tract cancers by sequencing of serum microRNAs.
Kim Kwondo et al. BMC medical genomics 2019 12(1) 62 - New PARP Inhibitor Approval for Pancreatic Cancer
L Schlager, FORCE, January 6, 2020 - Risk Assessment and Genetic Testing for Inherited Gastrointestinal Syndromes.
Stoll Jessica et al. Gastroenterology & hepatology 2019 Sep 15(9) 462-470
.jpeg)
No hay comentarios:
Publicar un comentario